Lunar Therapeutics (Lunar Tx) is a biotechnology company pioneering next-generation cell therapies for metabolic diseases. By leveraging advanced induced pluripotent stem cell (iPSC) technology, organoid engineering, and gene editing, Lunar Tx is developing off-the-shelf, vascularized islet organoids to restore insulin production and enhance patient outcomes.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.lunar-tx.com/
Lunar Therapeutics Questions
Lunar Therapeutics's website is https://www.lunar-tx.com/
Lunar Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lunar-therapeutics
Lunar Therapeutics's industry is
Biotechnology Research
Lunar Therapeutics's top competitors are
Arrowsmith Genetics,
Melius Microbiomics,
Verantos,
Sustainable Bioproduct Innovations,
Insu Therapeutics,
Kobra (Korea Bio Research Association),
Collage Biosciences,
Sinedore Medicine 正弦生醫,
Amphoraxe Life Sciences Inc.,
Inapill.
Lunar Therapeutics's categories are Biotechnology Research
